| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |